ANI Pharmaceuticals, Inc. (ANIP)
74.24
-1.12
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
74.24
0.00 (0.00%)
After-Hours: 19:20
ANI Pharmaceuticals Debt to Equity Ratio : 1.022 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.022 |
| March 31, 2026 | 1.092 |
| December 31, 2025 | 1.162 |
| September 30, 2025 | 1.249 |
| June 30, 2025 | 1.48 |
| March 31, 2025 | 1.547 |
| December 31, 2024 | 1.608 |
| September 30, 2024 | 1.602 |
| June 30, 2024 | 0.6804 |
| March 31, 2024 | 0.6866 |
| December 31, 2023 | 0.7287 |
| September 30, 2023 | 0.7229 |
| June 30, 2023 | 0.6585 |
| March 31, 2023 | 0.8434 |
| December 31, 2022 | 0.8524 |
| September 30, 2022 | 0.8579 |
| June 30, 2022 | 0.8558 |
| March 31, 2022 | 0.8308 |
| December 31, 2021 | 0.8049 |
| September 30, 2021 | 1.057 |
| June 30, 2021 | 1.068 |
| March 31, 2021 | 0.9023 |
| December 31, 2020 | 0.9504 |
| September 30, 2020 | 0.9655 |
| June 30, 2020 | 0.9966 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9962 |
| December 31, 2019 | 0.8752 |
| September 30, 2019 | 0.8778 |
| June 30, 2019 | 0.8968 |
| March 31, 2019 | 0.9235 |
| December 31, 2018 | 0.9278 |
| September 30, 2018 | 1.069 |
| June 30, 2018 | 1.105 |
| March 31, 2018 | 1.127 |
| December 31, 2017 | 1.153 |
| September 30, 2017 | 0.8276 |
| June 30, 2017 | 0.8745 |
| March 31, 2017 | 0.8855 |
| December 31, 2016 | 0.7111 |
| September 30, 2016 | 0.7037 |
| June 30, 2016 | 0.7143 |
| March 31, 2016 | 0.7192 |
| December 31, 2015 | 0.7086 |
| September 30, 2015 | 0.7389 |
| June 30, 2015 | 0.7603 |
| March 31, 2015 | 0.775 |
| December 31, 2014 | 0.7919 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Viatris, Inc. | 0.9555 |
| Liquidia Corp. | 0.9374 |
| Elanco Animal Health, Inc. | 0.5947 |
| Harmony Biosciences Holdings, Inc. | 0.2211 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.494B |
| Total Liabilities (Quarterly) | 896.90M |
| Shareholders Equity (Quarterly) | 597.21M |
| Current Ratio | 2.909 |
| Net Debt Paydown Yield | 0.39% |